Detalhe da pesquisa
1.
Genetic variation in TERT modifies the risk of hepatocellular carcinoma in alcohol-related cirrhosis: results from a genome-wide case-control study.
Gut
; 72(2): 381-391, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35788059
2.
Statistical perspectives on using hepatocellular carcinoma risk models to inform surveillance decisions.
J Hepatol
; 79(5): 1332-1337, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37210001
3.
Characterizing the risk interplay between alcohol intake and body mass index on cirrhosis morbidity.
Hepatology
; 75(2): 369-378, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34453350
4.
Delivery of biannual ultrasound surveillance for individuals with cirrhosis and cured hepatitis C in the UK.
Liver Int
; 43(4): 917-927, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36708150
5.
Evaluation of the aMAP score for hepatocellular carcinoma surveillance: a realistic opportunity to risk stratify.
Br J Cancer
; 127(7): 1263-1269, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35798825
6.
Performance of routine risk scores for predicting cirrhosis-related morbidity in the community.
J Hepatol
; 77(2): 365-376, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35271950
7.
Comparing Predicted Probability of Hepatocellular Carcinoma in Patients With Cirrhosis With the General Population: An Opportunity to Improve Risk Communication?
Am J Gastroenterol
; 117(9): 1454-1461, 2022 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35973177
8.
Declining incidence of hepatitis C related hepatocellular carcinoma in the era of interferon-free therapies: A population-based cohort study.
Liver Int
; 42(3): 561-574, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34951109
9.
Genome-Wide Association Study for Alcohol-Related Cirrhosis Identifies Risk Loci in MARC1 and HNRNPUL1.
Gastroenterology
; 159(4): 1276-1289.e7, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32561361
10.
Uptake of interferon-free DAA therapy among HCV-infected decompensated cirrhosis patients and evidence for decreased mortality.
J Viral Hepat
; 28(9): 1246-1255, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34002914
11.
Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study.
Gut
; 69(12): 2223-2231, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32217640
12.
Geospatial mapping and data linkage uncovers variability in outcomes of foot disease according to multiple deprivation: a population cohort study of people with diabetes.
Diabetologia
; 63(3): 659-667, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31848633
13.
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis.
J Hepatol
; 73(6): 1368-1378, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32707225
14.
Real-world impact following initiation of interferon-free hepatitis C regimens on liver-related outcomes and all-cause mortality among patients with compensated cirrhosis.
J Viral Hepat
; 27(3): 270-280, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31696575
15.
The contribution of health risk behaviors to excess mortality in American adults with chronic hepatitis C: A population cohort-study.
Hepatology
; 67(1): 97-107, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28777874
16.
Genetic data not yet a "game-changer" for predicting individualised hepatocellular carcinoma risk.
J Hepatol
; 78(3): 460-462, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592645
17.
Reply to: "Prediction of liver-related mortality in a community setting".
J Hepatol
; 78(4): e134-e135, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592644
18.
The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.
J Hepatol
; 68(3): 393-401, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29107152
19.
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen.
J Hepatol
; 68(4): 646-654, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29155019
20.
Inpatient hospital burden of hepatitis C-diagnosed patients with decompensated cirrhosis.
Liver Int
; 38(8): 1402-1410, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29288595